Confident Fentanyl Screening in Urine by HRAM Orbitrap Mass Spectrometer Analysis

Importance of the Topic

A rapid and reliable approach for screening fentanyl and its analogues in urine addresses the urgent public health challenge of rising synthetic opioid overdose deaths.

Study Objectives and Overview

• Demonstrate a high-resolution accurate mass (HRAM) Orbitrap Exploris 120 workflow for comprehensive fentanyl analogue screening.
• Apply the method to 212 compounds using the Thermo Scientific Fentanyl Analog Screening Kit (FAS Kit) and emergent panels in spiked human urine.

Methodology and Instrumentation

The workflow combined UHPLC separation, HRAM detection, and spectral library matching.

• Sample Preparation: Urine samples diluted 20× in water; 22 standard mixes (8–12 compounds) spiked at 100 ng/mL; calibration curves from 0.25 to 100 ng/mL.
• Liquid Chromatography: Vanquish Flex UHPLC with Accucore Phenyl Hexyl column (100×2.1 mm, 2.6 µm) at 40 °C; mobile phases of 2 mM ammonium formate/0.1% formic acid in water (A) and acetonitrile/methanol/water (50/50/1/0.1) (B); gradient optimized for baseline separation of isomers.
• Mass Spectrometry: Thermo Scientific Orbitrap Exploris 120 in positive ESI mode; accurate mass full scan and data-dependent MS/MS acquisition; spectral matching with mzVault and isotopic confirmation in TraceFinder software (v5.1).

Key Results and Discussion

• Over 212 fentanyl analogues were screened with retention time reproducibility (±0.1 min) and high mass accuracy (<5 ppm).
• Limits of detection (LOD) ranged from 0.25 to 5 ng/mL; limits of quantitation (LOQ) from 0.5 to 25 ng/mL; limits of identification (LOI) demonstrated consistent MS/MS and isotope matches.
• Chromatographic conditions effectively resolved positional isomers, minimizing false positives.
• High-quality MS/MS spectra enabled confident identification, even at low concentrations.

Benefits and Practical Applications

• Comprehensive coverage of current and emerging fentanyl analogues in a single run.
• High throughput: fast analysis (<10 min per injection) suitable for clinical, forensic, and QA/QC laboratories.
• Robust quantitation and screening in complex urine matrices with minimal sample preparation.
• Integration with automated data processing streamlines reporting and compliance.

Future Trends and Opportunities

• Expansion of spectral libraries to include novel synthetic opioids and other emerging drugs.
• Incorporation of parallel reaction monitoring (PRM) for targeted quantitation in clinical settings.
• Application of machine learning for automated feature detection and analogue prediction.
• Adaptation to high-throughput screening in mobile or point-of-care platforms.

Conclusion

The described HRAM Orbitrap Exploris 120 method provides a fast, sensitive, and comprehensive tool for fentanyl analogue screening in urine, meeting the needs of modern forensic and clinical toxicology.

Reference

Samra S. N., Hassell K., Van Natta K., Yang P., Correa T. Confident Fentanyl Screening in Urine by HRAM Orbitrap Mass Spectrometer Analysis. Thermo Fisher Scientific, 2021.